Wealthspire Advisors (Maryland)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$408K Sell
1,440
-645
-31% -$180K 0.01% 307
2020
Q2
$558K Sell
2,085
-60
-3% -$18K 0.04% 236
2020
Q1
$679K Sell
2,145
-142
-6% -$43.1K 0.06% 195
2019
Q4
$679K Buy
2,287
+21
+0.9% +$5.83K 0.05% 226
2019
Q3
$528K Buy
2,266
+44
+2% +$10.2K 0.04% 252
2019
Q2
$520K Sell
2,222
-173
-7% -$39.9K 0.04% 248
2019
Q1
$566K Sell
2,395
-19
-0.8% -$5.98K 0.04% 234
2018
Q4
$726K Buy
2,414
+52
+2% +$16.6K 0.06% 160
2018
Q3
$835K Buy
2,362
+110
+5% +$37.9K 0.07% 167
2018
Q2
$654K Sell
2,252
-158
-7% -$44.4K 0.06% 187
2018
Q1
$660K Sell
2,410
-224
-9% -$69.5K 0.06% 197
2017
Q4
$839K Buy
2,634
+177
+7% +$56.8K 0.08% 158
2017
Q3
$769K Buy
2,457
+87
+4% +$25.8K 0.08% 157
2017
Q2
$643K Buy
2,370
+68
+3% +$18K 0.08% 181
2017
Q1
$629K Sell
2,302
-49
-2% -$13.9K 0.09% 148
2016
Q4
$667K Buy
2,351
+36
+2% +$10.7K 0.1% 135
2016
Q3
$725K Sell
2,315
-5
-0.2% -$1.48K 0.11% 126
2016
Q2
$561K Buy
2,320
+163
+8% +$43K 0.09% 146
2016
Q1
$562K Buy
2,157
+642
+42% +$170K 0.1% 139
2015
Q4
$464K Buy
+1,515
New +$435K 0.09% 164

Other funds holding BIIB

Wealthspire Advisors (Maryland)'s BIIB Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its Biogen (BIIB) stake by 31% in Q3 2020, selling an estimated $180K and leaving 1,440 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #307.

Wealthspire Advisors (Maryland) first reported a position in BIIB in Q4 2015 and has held it in 20 quarters since. The position peaked at $839K in Q4 2017. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 1,440 shares of Biogen worth $408K as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 645 Biogen shares in Q3 2020, an estimated $180K.
  • Biogen made up 0.01% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #307 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Biogen in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s Biogen position peaked at $839K in Q4 2017.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.